The Intellisis Corporation

Regulus Therapeutics is a San Diego-based biopharmaceutical company dedicated to transforming the lives of patients and their families by delivering groundbreaking therapeutics for orphan kidney diseases. With a focus on high unmet needs, their pipeline programs, including ADPKD, target the underlying biology of these diseases using a novel and potentially powerful approach known as MicroRNA-based therapeutics. Driven by their mission, Regulus Therapeutics is committed to improving the lives of patients suffering from kidney diseases through their clinical trials and innovative research. Their recent completion of enrollment in the third cohort of a Phase 1b Multiple-Ascending Dose (MAD) clinical trial for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) showcases their dedication to advancing therapeutic solutions in this field.Generated from the website

Zenobia Therapeutics Inc is a San Diego-based company specializing in fragment-based lead discovery for the development of treatments for neurodegenerative diseases. With a focus on the central nervous system (CNS), their products and services have successfully yielded hits for a diverse range of targets worldwide. Founded in 2008, Zenobia Therapeutics expanded in 2014 to include Zenobia Fragments, a division dedicated to supplying highly core diverse fragments and unique reagents for protein solubilization and crystallization. Complementing their product offerings, Zenobia also provides screening and structural biology services to support fragment library purchases, solidifying their position as a leader in fragment-based lead discovery and CNS disease research.Generated from the website

ViaCyte is a biotechnology company based in San Diego, CA that focuses on developing innovative cell replacement therapies for diabetes. The company's research and development efforts are centered around creating potential long-term solutions for managing and treating the disease. Utilizing cutting-edge technology and scientific expertise, ViaCyte is dedicated to advancing the field of regenerative medicine to address the unmet needs of diabetic patients. With a mission to improve the quality of life for individuals living with diabetes, ViaCyte is committed to pioneering new approaches in the treatment of this chronic condition. Generated from their business information